Comparison of biochemical markers for the detection of minimal myocardial injury: Superior sensitivity of cardiac troponin - T ELISA

Journal of Internal Medicine

Volumn 247, Issue 1, 2000, Pages 119-123

  Lang, K ^a   Borner A ^a   Figulla, H R ^a  

^a FRIEDRICH SCHILLER UNIVERSITY JENA   (Germany)

Author keywords

Creatine kinase; Glycogen phosphorylase BB; Myoglobin; Troponin I; Troponin T; Unstable angina pectoris

Indexed keywords

BIOCHEMICAL MARKER; CREATINE KINASE; CREATINE KINASE MB; GLYCOGEN PHOSPHORYLASE B; MYOGLOBIN; TROPONIN I; TROPONIN T;

ADULT; ARTICLE; CLINICAL ARTICLE; DIAGNOSTIC ACCURACY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HEART INFARCTION; HEART MUSCLE BIOPSY; HEART MUSCLE INJURY; HUMAN; MALE; MYOCARDITIS; PRIORITY JOURNAL; UNSTABLE ANGINA PECTORIS;

ADULT; ANGINA, UNSTABLE; CREATINE KINASE; DIAGNOSIS, DIFFERENTIAL; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; MYOCARDITIS; MYOGLOBIN; PHOSPHORYLASES; SENSITIVITY AND SPECIFICITY; TIME FACTORS; TROPONIN I; TROPONIN T;

EID: 0033964025     PISSN: 09546820     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2796.2000.00594.x     Document Type: Article

References (28)

1. 1 Katus HA, Kübler W. Detection of myocardial cell damage in patients with unstable angina by serodiagnostic tools. In: Bleifeld W, Hamm CW, Braunwald, eds. Unstable Angina. Berlin: Springer Verlag, 1990: 92-102.
2. 2 Hamm CW, Ravkilde J. Gerhardt WL, Jorgensen P, Peheim E, Ljungdahl L, et al. The prognostic value of serum Troponin T in unstable angina. New Engl J Med 1992; 327: 146-50.
3. 3 Gerhardt W, Ljungdahl L. Rational diagnostic strategy in diagnosis of ischemic myocardial injury. S-troponin T and S-CK-MB (mass) time series using individual baseline values. Scand J Clin Lab Invest 1993; 53 (Suppl.): 47-59.
4. 4 Hamm CW, Goldmann BU, Heeschen C, Kreymann G, Berger J. Meinertz T. Emergency room triage of patients with acute chest pain by means of rapid testing for cardiac Troponin T or Troponin I. New Engl J Med 1997; 337: 1648-53.
5. 5 de Winter RJ. Koster RW, Sturk A, Sanders G. Value of Myoglobin, Troponin T, and CK-MB mass in ruling out an acute myocadial infarction in the emergency room. Circulation 1995; 92: 3401-7.
6. 6 Ravkilde J, Nissen H. Horder M, Thygesen K. Independent prognostic value of serum Creatine Kinase Isoenzyme MB mass, cardiac Troponin T and Myosin Light Chain levels in suspected acute myocardial infarction. JACC 1995; 25: 574-81.
7. 7 Rabitzsch G. Mair J, Lechleitner P, Noll F, Hofmann U, Krause EG, et al. Isoenzyme BB of glycogen phosphorylase b and myocardial infarction. Lancet 1993; 341: 1032.
8. 8 Rabitzsch G, Mair J. Lechleitner F. Noll F, Hofmann U. Krause EG, et al. Immunoenzymometric assay of human glycogen phosphorylase isoenzyme BB in diagnosis of ischemic myocardial injury. Clin. Chem 1995; 41; 966-78.
9. 9 Ravkilde J. Creatine kinase isoenzyme MB mass, cardiac troponin T, and myosin light chain isotype 1 as serological markers of myocardial injury and their prognostic importance in acute coronary syndrome. Danish Medical Bulletin 1998; 45: 34-50.
10. 10 Oliver IT. A spectrophotometric method for the determination of creatine phosphokinase and myokinase. Biochem J 1955; 61: 116.
11. 11 Rosalki SB. An improved procedure for serum creatine phosphokinase determination. J Lab Clin Med 1967; 69: 696-705.
12. 12 Neumeier D. Prellwitz W, Würzburg U, Brundobler M, Olbermann M, Just HJ, et al. Determination of creatine kinase isoenzyme MB activity in serum using immunological inhibition of creatine kinase M subunit activity. Clin Chim Acta 1976; 73: 445-51.
13. 3 Katus HA, Looser S. Hallermayer K, Remppis-A, Scheffold-T, Borgya-A, et al. Development and in vitro characterisation of a new immunoassay of cardiac Troponin T. Clin Chem 1992; 38: 386-93.
14. 14 Krause EG, Will H, Boehm M. Wollenberger A. The assay of glycogen phosphorylase in human blood serum and its application to the diagnosis of myocardial infarction. Clin Chim Acta 1975: 58: 145-54.
15. 15 Michael LH. Hunt JR, Weilbaecher D, Ferryman MB. Roberts R, Lewis RM, Entmann ML. Creatine kinase and phosphorylase in cardiac lymph: Coronary occlusion and reperfusion. Am J. Physiol 1985; 248: 350-9.
16. 16 Rabitzsch G, Schulz H, Onnen K, Koessler A, Kraus EG. Immunoinhibition assay of the serum activity of human glycogen isophosphorylase BB in the diagnosis of acute myocardial ischemia. Biomed. Biochim Acta 1987: 46: 584-8.
17. 17 Mair P, Mair J. Grause EG, Balogh D, Puschendorf B. Rabitsch G. Glycogen phosphorylase isoenzyme BB mass release after coronary artery bypass grafting. Eur. J. Clin, Chem. Clin. Biochem 1994; 32: 543-7.
18. 18 Adams JE, Schechtman KB, Landt Y, Ladenson JH, Jaffe AS. Comparable detection of acute myocardial infarction by creatine kinase MB isoenzyme and cardiac troponin I. Clin. Chem 1994; 40: 1291-5.
19. 19 Katus HA, Remppis A, Neumann EJ. Scheffold T, Diederich KW, Vinar G, et al. Diagnostic efficiency of troponin T measurements in acute myocardial infarction. Circulation 1991; 83: 902-12.
20. 20 Voss EM, Sharkey SW, Gernert AE, Murakami MM, Johnson RB, Hsieh CC, et al. Human and canine cardiac troponin T and creatine kinase-MB distribution in normal and diseased myocardium: infaret sizing using serum profiles. Arch. Pathol. Lab. Med 1995; 199: 799-806.
21. 21 Alonsozana GL, Christenson RH. The Case for cardiac troponin T. marker for effective risk stratification of patients with acute cardiac ischemia. Clin Chem 1996; 42: 803-8.
22. 22 Ohman EM, Armstrong PW, Christenson RH, Granger CB, Katus HA, Hamm CW for the GUSTO-IIa-Investigators. Cardiac Troponin T levels for risk stratification in acute myocardial ischemia. N Engl. J. Med 1996; 335: 1 333-41.
23. 23 Stubbs P, Collinson P, Moseley D, Greenwood T, Noble M. Prospective study of the role of cardiac troponin T in patients admitted with unstable angina. Brit. Med. J 1996; 313: 262-4.
24. 24 Lindahl B, Venge P, Wallentin T,. for the FRISC study group. Troponin T identifies patients with unstable coronary artery disease who benefit from long-term antithrombotic protection. JACC 1997; 29: 43-8.
25. 25 Lindahl B. Venge P. Wallentin L. for the FRISC study group. Relation between Troponin T and the risk of subsequent cardiac events in unstable coronary artery disease. Circulation 1996; 93: 1651-7.
26. 26 Ravkilde J. Nissen H, Mickley H, Andersen PE, Thayssen P, Horder M. Cardiac troponin T and CK-MB mass release after visually successful percutaneous transluminal coronary angioplasty in stable angina pectoris. Am Heart J 1994; 137: 13-20.
27. 27 Mair J, Puschendorf B, Schmidt J, Lechleitner-P, Dienstl-F, Noll-F, et al. Early release of glycogenphosphorylase in patients with unstable angina and transient ST-T alterations. Br Heart J 1994; 72: 125-7.
28. 28 Hamm CW, Heeschen C, Goldmann B, Vahanian A. Adgey J. Miguel CM, et al. for the c7E3 Fab antiplatelet therapy in unstable refractory angina (CAPTURE) study investigators: Benefit of abciximab in patients with refractory unstable angina in relation to serum troponin T levels. N Engl. J. Med. 1999; 340: 1623-9.